High-Throughput Brain Injury Proteomic Microassay

Award Information
Agency:
Department of Defense
Branch
Office of the Secretary of Defense
Amount:
$100,000.00
Award Year:
2005
Program:
STTR
Phase:
Phase I
Contract:
W81XWH-05-C-0172
Award Id:
76634
Agency Tracking Number:
O054-003-2024
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
535 W. Research Blvd., Suite 135, M/S 400, Fayetteville, AR, 72701
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
125518428
Principal Investigator:
PrabhuArumugam
Senior Engineer
(479) 571-2592
prabhu.arumugam@sfc-fluidics.com
Business Contact:
MarkWagstaff
Vice President
(479) 571-2592
mwagstaff@virtual-incubation.com
Research Institute:
UNIV. OF ARKANSAS
Rosemary Ruff
Research and Sponsored Program, 120 Ozark Hall
Fayetteville, AR, 72701
(479) 575-3845
Nonprofit college or university
Abstract
SFC Fluidics in coordination with the University of Arkansas proposes to develop an immunoassay based lab-on-a-chip using the advantages of self-contained microelectrochemical detection and redox magnetohydrodynamic (MHD) microfluidics for the rapid detection of biomarkers of traumatic brain injury (TBI) from a pinprick sample of blood. The disposable cartridge will contain all of the reagents necessary to complete the assay and will move the components of the assay along preprogrammed paths. All that the user will need to do is inject a known quantity of blood serum from a patient, push a button and wait ~30 min for a digital readout of results. The instrument will be designed to be sturdy and compact as would be necessary for diagnosing a soldier in the field. In Phase I we will demonstrate the microelectrochemical-based assay platform to simultaneously detect two TBI biomarkers in blood serum for which monoclonal antibodies are commercially available. Phase I will also focus on the manipulation of the immunoassay components in a redox magnetohydrodynamic (MHD) based microfluidic network to show feasibility. This microelectrochemical assay/MHD microfluidic cartridge can be expanded later in Phase II to incorporate many other biomarkers for TBI and allow for portability and complete automation.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government